Date Title
October 15, 2018
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 0349E Realm Therapeutics PLC 15 October 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
October 9, 2018
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 4161D Realm Therapeutics PLC 09 October 2018   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
October 1, 2018
Realm Therapeutics - Provides Update on Timing of Formal Sale Process
RNS Number : 4338C Realm Therapeutics PLC 01 October 2018   Realm Therapeutics plc (" Realm Therapeutics ", "Realm" or the "Company")   Provides Update on Timing of Formal Sale Process     MALVERN, PA , October 1, 2018 - Realm Therapeutics plc (NASDAQ:RLM / AIM:RLM), a biopharmaceutical company
September 20, 2018
Realm Therapeutics - Holding(s) in Company
RNS Number : 4560B Realm Therapeutics PLC 20 September 2018   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of
September 19, 2018
Realm Therapeutics - Form 8 (OPD) - Realm Therapeutics plc
RNS Number : 3126B Realm Therapeutics PLC 19 September 2018   FORM 8 (OPD)   PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: REALM THERAPEUTICS PLC (b) Owner or controller of
September 17, 2018
Realm Therapeutics - Corporate Update and Hiring of Advisor

RNS Number : 8941A Realm Therapeutics PLC 17 September 2018   THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULA TION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY

August 20, 2018
Realm Therapeutics - Price Monitoring Extension
RNS Number : 2946Y Realm Therapeutics PLC 20 August 2018   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of
August 20, 2018
Realm Therapeutics - Block listing Interim Review
RNS Number : 2070Y Realm Therapeutics PLC 20 August 2018   Realm Therapeutics plc Block Listing Interim Review   Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies Realm Therapeutics plc makes the following update on its block listing:   Date:  20 August 2018   Name of applicant:
August 15, 2018
Realm Therapeutics - Price Monitoring Extension
RNS Number : 9378X Realm Therapeutics PLC 15 August 2018   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of
August 14, 2018
Realm Therapeutics - Half-year Report

RNS Number : 7159X Realm Therapeutics PLC 14 August 2018   THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULA TION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY

Displaying 31 - 40 of 150

Search Investor Relations